Showing 151 - 160 of 44,063
Persistent link: https://www.econbiz.de/10014507649
We study the effect of price caps on the provision of costly effort by pharmaceutical firms using variation in drug discounts generated by a price regulation program that allows eligible hospitals to purchase outpatient drugs at steep discounts. These discounts directly affect drug...
Persistent link: https://www.econbiz.de/10014512103
The extent of pharmaceutical advertising and promotion can be characterized by a balancing act between profitable … demand expansions and potentially unfavorable subsequent regulatory actions. However, this balance also depends on the nature … scenarios and test the model's predictions using a novel combination of sales, promotion, advertising, and adverse event reports …
Persistent link: https://www.econbiz.de/10012461495
In this paper, we investigate the change in advertising patterns of competing pharmaceutical firms in the short period … that Crestor’s main competitor, Lipitor, increases its advertising intensity the most among physicians with whom Crestor … already has a median share of total prescriptions. Moreover, such change in advertising patterns does not occur with Crestor …
Persistent link: https://www.econbiz.de/10014204406
Persistent link: https://www.econbiz.de/10013449296
The aim of this paper is to empirically analyse the responses by general practitioners to promotional activities for ethical drugs by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be harmful in the sense that it lowers price...
Persistent link: https://www.econbiz.de/10014058923
pharmaceuticals by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be …
Persistent link: https://www.econbiz.de/10014072054
This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends crucially on the cost effectiveness of...
Persistent link: https://www.econbiz.de/10013329470
This paper theoretically and empirically examines the role of information in the practice of pharmaceutical detailing (promotional interactions between drug representatives and physicians). We start with a theoretical framework in which pharmaceutical firms target detailing visits to physicians...
Persistent link: https://www.econbiz.de/10014382628
Persistent link: https://www.econbiz.de/10013435486